Inventor
ADAM JUDGE
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
C12NMicroorganisms or enzymes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
Y02ATechnologies for adaptation to climate change10%
B82YSpecific uses or applications of nanostructures7%
C07HSugars7%
C07JSteroids7%
C07KPeptides3%
PatentTitleYear
12,251,470Lipid nanoparticle formulations202512,043,833Targeted compositions202412,016,929Lipid formulations for delivery of therapeutic agents202411,786,598Lipid formulations for delivery of therapeutic agents202311,446,383Lipid formulations for delivery of therapeutic agents202211,427,823Targeted compositions202211,191,849Compositions and methods for delivering messenger RNA2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to ARBUTUS BIOPHARMA CORP (7)· patent assignee history
2021–2025Based in US· patent location history
2022–2024Based in CA· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARBUTUS BIOPHARMA CORP | 7 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2021–2025 |
| CA | 3 | 2022–2024 |